DE60004803D1 - Pulmonare abgabe von protonierter/angesäuerter nukleinsäure - Google Patents
Pulmonare abgabe von protonierter/angesäuerter nukleinsäureInfo
- Publication number
- DE60004803D1 DE60004803D1 DE60004803T DE60004803T DE60004803D1 DE 60004803 D1 DE60004803 D1 DE 60004803D1 DE 60004803 T DE60004803 T DE 60004803T DE 60004803 T DE60004803 T DE 60004803T DE 60004803 D1 DE60004803 D1 DE 60004803D1
- Authority
- DE
- Germany
- Prior art keywords
- nucleic acid
- protonanized
- nucleic acids
- pulmonary delivery
- acidified nucleic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7088—Compounds having three or more nucleosides or nucleotides
- A61K31/7125—Nucleic acids or oligonucleotides having modified internucleoside linkage, i.e. other than 3'-5' phosphodiesters
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N57/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic phosphorus compounds
- A01N57/10—Biocides, pest repellants or attractants, or plant growth regulators containing organic phosphorus compounds having phosphorus-to-oxygen bonds or phosphorus-to-sulfur bonds
- A01N57/16—Biocides, pest repellants or attractants, or plant growth regulators containing organic phosphorus compounds having phosphorus-to-oxygen bonds or phosphorus-to-sulfur bonds containing heterocyclic radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/60—Sugars; Derivatives thereof
- A61K8/606—Nucleosides; Nucleotides; Nucleic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/02—Local antiseptics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
- C07H21/02—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids with ribosyl as saccharide radical
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biotechnology (AREA)
- Dentistry (AREA)
- Genetics & Genomics (AREA)
- Dermatology (AREA)
- Communicable Diseases (AREA)
- Birds (AREA)
- Agronomy & Crop Science (AREA)
- Pest Control & Pesticides (AREA)
- Plant Pathology (AREA)
- Oncology (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Environmental Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/282,824 US6211162B1 (en) | 1998-12-30 | 1999-03-31 | Pulmonary delivery of protonated/acidified nucleic acids |
PCT/US2000/008244 WO2000057890A1 (en) | 1999-03-31 | 2000-03-28 | Pulmonary delivery of protonated/acidified nucleic acids |
Publications (1)
Publication Number | Publication Date |
---|---|
DE60004803D1 true DE60004803D1 (de) | 2003-10-02 |
Family
ID=23083287
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE60004803T Expired - Lifetime DE60004803D1 (de) | 1999-03-31 | 2000-03-28 | Pulmonare abgabe von protonierter/angesäuerter nukleinsäure |
Country Status (7)
Country | Link |
---|---|
US (1) | US6211162B1 (de) |
EP (1) | EP1169046B1 (de) |
JP (1) | JP4883840B2 (de) |
AT (1) | ATE247972T1 (de) |
AU (1) | AU781560B2 (de) |
DE (1) | DE60004803D1 (de) |
WO (1) | WO2000057890A1 (de) |
Families Citing this family (36)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5855911A (en) * | 1995-08-29 | 1999-01-05 | Board Of Regents, The University Of Texas System | Liposomal phosphodiester, phosphorothioate, and P-ethoxy oligonucleotides |
US7309692B1 (en) * | 1996-07-08 | 2007-12-18 | Board Of Regents, The University Of Texas System | Inhibition of chronic myelogenous leukemic cell growth by liposomal-antisense oligodeoxy-nucleotides targeting to GRB2 or CRK1 |
US6977244B2 (en) * | 1996-10-04 | 2005-12-20 | Board Of Regents, The University Of Texas Systems | Inhibition of Bcl-2 protein expression by liposomal antisense oligodeoxynucleotides |
US7285288B1 (en) | 1997-10-03 | 2007-10-23 | Board Of Regents, The University Of Texas System | Inhibition of Bcl-2 protein expression by liposomal antisense oligodeoxynucleotides |
US7704962B1 (en) | 1997-10-03 | 2010-04-27 | Board Of Regents, The University Of Texas System | Small oligonucleotides with anti-tumor activity |
US8933032B2 (en) | 1998-10-20 | 2015-01-13 | Children's Hospital Medical Center | Surfactant protein D for the treatment of disorders associated with lung injury |
US6627215B1 (en) * | 1998-12-30 | 2003-09-30 | Oligos Etc. Inc. | Devices for improved wound management |
US7868162B2 (en) * | 1998-12-30 | 2011-01-11 | Lakewood-Amedex, Inc. | Antimicrobial and antiviral compounds and methods for their use |
US6651655B1 (en) * | 2000-01-18 | 2003-11-25 | Quadrant Technologies Limited | Inhaled vaccines |
WO2002028367A1 (fr) * | 2000-10-04 | 2002-04-11 | Kyowa Hakko Kogyo Co., Ltd. | Procede de revetement de particules fines avec un film de lipides |
EP1414841B1 (de) | 2001-07-10 | 2012-11-14 | Lakewood-Amedex, Inc | Oligonukleotidhaltige pharmakologische zusammensetzungen und deren verwendung |
EP1460898A4 (de) * | 2002-01-03 | 2006-05-24 | Univ Texas | Wt1-antisense-oligos für die hemmung von brustkrebs |
CA2477979A1 (en) * | 2002-03-05 | 2003-09-18 | Transave, Inc. | An inhalation system for treatment of intracellular infections |
AU2003276131A1 (en) * | 2002-06-18 | 2003-12-31 | Epigenesis Pharmaceuticals, Inc. | A dry powder oligonucleotide formulation, preparation and its uses |
KR101301653B1 (ko) * | 2002-10-29 | 2013-08-30 | 트랜세이브, 인코포레이티드 | 항감염제의 지속적인 방출 |
US7879351B2 (en) * | 2002-10-29 | 2011-02-01 | Transave, Inc. | High delivery rates for lipid based drug formulations, and methods of treatment thereof |
US7718189B2 (en) * | 2002-10-29 | 2010-05-18 | Transave, Inc. | Sustained release of antiinfectives |
DE10361502A1 (de) * | 2003-12-23 | 2005-07-28 | Phenion Gmbh & Co. Kg | Kosmetische oder pharmazeutische Zubereitungen enthaltend Superstruktur-bildende Nukleinsäure-Sequenzen |
US20110177996A1 (en) * | 2005-05-23 | 2011-07-21 | Children's Hospital Medical Center | Regulatory proteins in lung repair and treatment of lung disease |
CA2617484A1 (en) * | 2005-08-03 | 2007-02-15 | Morria Biopharmaceuticals | Use of lipid conjugates in cystic fibrosis and applications thereof |
US20110130555A1 (en) | 2009-05-11 | 2011-06-02 | Saul Yedgar | Lipid-polymer conjugates, their preparation and uses thereof |
CA2838111C (en) | 2005-12-08 | 2016-01-19 | Insmed Incorporated | Lipid-based compositions of antiinfectives for treating pulmonary infections and methods of use thereof |
US20100196455A1 (en) | 2007-05-04 | 2010-08-05 | Transave, Inc. | Compositions of Multicationic Drugs for Reducing Interactions with Polyanionic Biomolecules and Methods of Use Thereof |
US9119783B2 (en) | 2007-05-07 | 2015-09-01 | Insmed Incorporated | Method of treating pulmonary disorders with liposomal amikacin formulations |
US9333214B2 (en) | 2007-05-07 | 2016-05-10 | Insmed Incorporated | Method for treating pulmonary disorders with liposomal amikacin formulations |
US9114081B2 (en) | 2007-05-07 | 2015-08-25 | Insmed Incorporated | Methods of treating pulmonary disorders with liposomal amikacin formulations |
KR102277921B1 (ko) | 2012-05-21 | 2021-07-14 | 인스메드 인코포레이티드 | 폐 감염을 치료하기 위한 시스템 |
EP3581186A1 (de) | 2012-11-29 | 2019-12-18 | Insmed Incorporated | Stabilisierte vancomycin-formulierungen |
PL3142643T3 (pl) | 2014-05-15 | 2019-12-31 | Insmed Incorporated | Sposoby leczenia zakażeń płuc prątkami niegruźliczymi |
EP3592430B1 (de) | 2017-03-10 | 2024-06-26 | Lakewood Amedex, Inc. | Antimikrobielle verbindungen, zusammensetzungen sowie verwendungen davon |
US11377468B2 (en) | 2017-03-10 | 2022-07-05 | Lakewood Amedex, Inc. | Antimicrobial compounds, compositions, and uses thereof |
US11795192B2 (en) | 2017-03-10 | 2023-10-24 | Lakewood Amedex, Inc. | Antimicrobial compounds, compositions, and uses thereof |
CA3066722A1 (en) | 2017-06-12 | 2018-12-20 | Lakewood Amedex, Inc | Bisphosphocin gel formulations and uses thereof |
EP3773505A4 (de) | 2018-03-30 | 2021-12-22 | Insmed Incorporated | Verfahren zur kontinuierlichen herstellung von liposomalen arzneimittelprodukten |
US11365413B2 (en) * | 2018-08-22 | 2022-06-21 | Board Of Regents, The University Of Texas System | Inhibition of poly(A) binding protein and the treatment of pain |
US11123357B2 (en) | 2018-10-17 | 2021-09-21 | Lakewood Amedex, Inc. | Methods and compositions for treating oral mucositis |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5115637A (en) * | 1974-07-26 | 1976-02-07 | Yukio Kobayashi | Ch3 cooh to pentakurorufuenoorunokongonyoru satsukinseibutsushitsu |
CA1231053A (en) * | 1984-01-09 | 1988-01-05 | Capetrol International, Inc. | Germicides having ph values of less than about l |
US5294533A (en) | 1988-07-05 | 1994-03-15 | Baylor College Of Medicine | Antisense oligonucleotide antibiotics complementary to the macromolecular synthesis operon, methods of treating bacterial infections and methods for identification of bacteria |
ZA902710B (en) * | 1989-05-22 | 1991-12-24 | Univ Georgia Res Found | Enzyme luminescence assay |
IL108206A0 (en) * | 1993-01-06 | 1994-04-12 | Univ Johns Hopkins | Oligomers having improved stability at acid ph |
US5739309A (en) * | 1993-07-19 | 1998-04-14 | Gen-Probe Incorporated | Enhancement of oligonucleotide inhibition of protein production, cell proliferation and / or multiplication of infectious disease pathogens |
GB9505438D0 (en) | 1995-03-17 | 1995-05-03 | Sod Conseils Rech Applic | Antisense oligonucleotides |
US6025339A (en) * | 1995-06-07 | 2000-02-15 | East Carolina University | Composition, kit and method for treatment of disorders associated with bronchoconstriction and lung inflammation |
AU3811897A (en) * | 1996-07-24 | 1998-02-10 | Oglios Therapeutics, Inc. | Antisense oligonucleotides as antibacterial agents |
US6211349B1 (en) * | 1998-12-30 | 2001-04-03 | Oligos Etc., Inc. | Protonated/acidified nucleic acids and methods of use |
-
1999
- 1999-03-31 US US09/282,824 patent/US6211162B1/en not_active Expired - Lifetime
-
2000
- 2000-03-28 DE DE60004803T patent/DE60004803D1/de not_active Expired - Lifetime
- 2000-03-28 EP EP00921487A patent/EP1169046B1/de not_active Expired - Lifetime
- 2000-03-28 AU AU41796/00A patent/AU781560B2/en not_active Ceased
- 2000-03-28 AT AT00921487T patent/ATE247972T1/de not_active IP Right Cessation
- 2000-03-28 JP JP2000607640A patent/JP4883840B2/ja not_active Expired - Fee Related
- 2000-03-28 WO PCT/US2000/008244 patent/WO2000057890A1/en active IP Right Grant
Also Published As
Publication number | Publication date |
---|---|
AU4179600A (en) | 2000-10-16 |
AU781560B2 (en) | 2005-06-02 |
WO2000057890A1 (en) | 2000-10-05 |
ATE247972T1 (de) | 2003-09-15 |
JP2002540160A (ja) | 2002-11-26 |
EP1169046B1 (de) | 2003-08-27 |
EP1169046A1 (de) | 2002-01-09 |
JP4883840B2 (ja) | 2012-02-22 |
US6211162B1 (en) | 2001-04-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE60004803D1 (de) | Pulmonare abgabe von protonierter/angesäuerter nukleinsäure | |
ATE347277T1 (de) | Zusammensetzung mit bakteriostatischen und bakteriziden eigenschaften gegen bakterielle sporen und zellen und verfahren zu deren verwendung zur behandlung von lebensmitteln | |
ATE328893T1 (de) | Antibakterielle protonierte oligonukleotide | |
DE60134855D1 (de) | Orale zubereitungen, die antimikrobielle wirkstoffe enthalten zur prävention von systemischen erkrankungen | |
ATE191477T1 (de) | Dihalopropenverbindungen, diese enthaltende insektizide/acarizide mittel und zwischenprodukte zur herstellung davon | |
ATE305720T1 (de) | Bakterizide desinfizierende peressigsäure- zusammensetzung | |
RU94008616A (ru) | 2-тиозамещенные карбапенемы, промежуточные соединения для получения, способы получения, фармацевтическая композиция, способ лечения бактериальных инфекций | |
BG104913A (en) | 15-membered lactams ketolides with antibacterial activity | |
YU13699A (sh) | Primena 1-hidroksi-2-piridona za dobijanje leka za lečenje infekcija kože | |
NO20023630L (no) | Anvendelse av retinoid-type forbindelser som antibakterielle midler | |
ATE205505T1 (de) | Basische oxazolinamid-derivate von ge2270 und ge2270-änlichen antibiotika | |
DE69600244D1 (de) | Basische prolinamid derivate von ge2270 und ge2270-ahnlichten antibiotika | |
BR0009101A (pt) | 9a-azalidas com atividade antibacteriana | |
CA2386685A1 (en) | Use of pleuromutilin derivatives for transdermal treatment of bacterial diseases | |
ATE260097T1 (de) | Hopfensäuren zur hemmung von staphylococcus aureus | |
AU740327C (en) | Carbapenem compounds, use thereof and intermediate compound therefor | |
ES2113391T3 (es) | Factor c2a de antibiotico ge 2270. | |
HUP0003845A2 (hu) | Antimikrobiális 8a-azalidok alkalmazása | |
ES2112517T3 (es) | Antibioticos ge 37468 a, b y c. | |
HUP0401586A2 (hu) | Baktériumellenes szer | |
BG101996A (en) | 9-n-ethylenederivatives of 9(s)-erythromycylamine | |
HUP0000146A2 (hu) | Eljárás Streptococcus pneumoniae-fertőzés kezelésére | |
RU94007001A (ru) | Соли 2-морфолино-5-фенил-6н-1,3,4-тиадиазина и 4,7-дигидро-6-нитро-7-оксо-/1,2,4/-триазоло /5,1-с// 1,2,4/-триазинов, обладающие бактерицидной активностью в отношении возбудителя микоплазмоза | |
JPH0237882B2 (ja) | Chikusandobutsunodensenseishitsukannoyokuseihoho | |
ATE234320T1 (de) | Beta,beta-disubstituierte derivate von 9-deoxo-9a-n-ethenyl-9a-aza-9a-homoerythromycin a |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8332 | No legal effect for de |